Additionally, multiple studies have demonstrated the overexpression of eIF4A3 in various malignancies, including HCC, gastric cancer, epithelial ovarian cancer, and ovarian cancer. This evidence concerns the gene EIF4A3 and hepatocellular carcinoma.